UK markets closed
NIKKEI 225
38,079.70 +117.90 (+0.31%) HANG SENG
16,385.87 +134.03 (+0.82%) CRUDE OIL
82.80 +0.11 (+0.13%) GOLD FUTURES
2,397.10 +8.70 (+0.36%) DOW
37,790.63 +37.32 (+0.10%) Bitcoin GBP
50,867.00 +1,732.67 (+3.53%)
Evoke Pharma, Inc. (EVOK)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 03:03PM EDT. Market open.
| Previous close | 0.5500 |
| Open | 0.5490 |
| Bid | 0.3526 x 200 |
| Ask | 0.6890 x 200 |
| Day's range | 0.5038 - 0.5699 |
| 52-week range | 0.4160 - 2.4200 |
| Volume | |
| Avg. volume | 48,159 |
| Market cap | 4.271M |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
We feel now is a pretty good time to analyse Evoke Pharma, Inc.'s ( NASDAQ:EVOK ) business as it appears the company...
- Insider Monkey
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript March 14, 2024 Evoke Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.5. Evoke Pharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, […]
- Thomson Reuters StreetEvents
Q4 2023 Evoke Pharma Inc Earnings Call
Q4 2023 Evoke Pharma Inc Earnings Call
© 2024 Yahoo. All rights reserved.